Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2010
07/08/2010US20100172893 Use of Reversine and Analogs For Treatment of Cancer
07/08/2010US20100172890 Agmatine containing dietary supplements, nutraceuticals, and foods
07/08/2010US20100172881 Use of tailored recombinases for the treatment of retroviral infections
07/08/2010US20100172878 Polynucleotides encoding mhc class i-restricted htert epitopes, analogues thereof or polyepitopes
07/08/2010US20100172875 Oil-in-water emulsion and its use for the delayed release of active elements
07/08/2010US20100172870 Methods, uses and compositions for modulating replication of hcv through the farnesoid x receptor (fxr) activation or inhibition
07/08/2010US20100172867 Substituted 1h-pyrazolo[3,4-d]pyrimidine-6-amine compounds
07/08/2010US20100172866 Combination Therapy for the Treatment of HCV Infection
07/08/2010US20100172861 Anionic Polymers as Toxin Binders and Antibacterial Agents
07/08/2010US20100172860 Wound repair composition and method
07/08/2010US20100172854 Antibacterial formulations
07/08/2010US20100172851 Hydroxy-oligocarboxylic esters: effects on nerve and use for cutaneous and mucocutaneous organs or sites
07/08/2010US20100172848 Skin and surface disinfectant compositions containing botanicals
07/08/2010US20100172844 Albumin binding molecules and uses thereof
07/08/2010US20100172832 Diagnosis and treatment of malignant neoplasms
07/08/2010US20100170849 Buffered compositions for dialysis
07/08/2010DE202010004094U1 Orale Zusammensetzung eines Antipsychotikums mit verzögerter Freisetzung The oral composition of antipsychotic sustained release
07/08/2010DE10332560B4 Verfahren zur Herstellung von ß- Heteroaryl-2-alanin-Verbindungen über 2-Amino-2-(heteroarylmethyl)-carbonsäure-Verbindungen Process for the preparation of .beta.-heteroaryl-2-alanine compounds 2-amino-2- (heteroarylmethyl) -carboxylic acid compounds
07/08/2010DE102009022414A1 Antibakterielle Verwendung eines Extrakts aus Morus australis Poir. Antibacterial use of an extract of Morus australis Poir. und der Verbindung Kuwanon H and the connection Kuwanon H
07/08/2010DE102009005865A1 Dosiereinheit und Zusammensetzung zur Behandlung von entzündlichen Erkrankungen des Mund- und Rachenraums Dosing and composition for the treatment of inflammatory diseases of the mouth and throat
07/08/2010DE102009003980A1 Propofol in triheptanoinhaltiger Trägeremulsion Propofol emulsion carrier in triheptanoinhaltiger
07/08/2010DE102009003975A1 Benzothiazolonderivate Benzothiazolonderivate
07/08/2010DE102009003954A1 Pyridazinonderivate Pyridazinone derivatives
07/08/2010DE102004012273B4 Stabile und geschmacksmaskierte pharmazeutische Dosierungsform unter Verwendung von porösen Apatit-Körnern Stable and taste masked pharmaceutical dosage form using porous apatite grains
07/08/2010CA2823331A1 Companion animal compositions including lipoic acid and methods of use thereof
07/08/2010CA2783331A1 Pregnenolone sulfate for the treatment of neurologic disorders
07/08/2010CA2750196A1 Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
07/08/2010CA2750153A1 Biological oil composition, formulations comprising the oil composition, and use thereof to prevent or treat cardiovascular disease
07/08/2010CA2750144A1 Opioid-containing oral pharmaceutical compositions and methods
07/08/2010CA2750140A1 Methods of treating or preventing degenerative joint conditions, osteoarthristis, cartilage damage, and related disorders in companion animals
07/08/2010CA2748982A1 Thienopyridines as pharmacologically active agents
07/08/2010CA2748853A1 Polymorphic form of 5-chloro-n-{[(5s)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]oxa-zolidin-5-yl]-methyl}thiophene-2-carboxamide
07/08/2010CA2748788A1 Adjuvant compositions and methods of use
07/08/2010CA2748783A1 Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
07/08/2010CA2748729A1 Sulfated c-glycoside, method for isolating same and method for synthesizing same
07/08/2010CA2748728A1 Tablet containing cetirizine, pseudoephedrine, and naproxen containing a barrier layer
07/08/2010CA2748719A1 Anti-viral compounds, treatment, and assay
07/08/2010CA2748607A1 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
07/08/2010CA2748546A1 Sphingo-guanidines and their use as inhibitors of sphingosine kinase
07/08/2010CA2748491A1 Substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
07/08/2010CA2748490A1 Substituted diketopiperazine analogs for use as drug delivery agents
07/08/2010CA2748441A1 Vitamin d promoting sunscreen
07/08/2010CA2748413A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
07/08/2010CA2748411A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof as hif activators
07/08/2010CA2748409A1 Pharmaceutical formulations of olmesartan
07/08/2010CA2748331A1 Sulfonamide compounds for the treatment of respiratory disorders
07/08/2010CA2748276A1 Substituted pyrazolo [3, 4-b] pyridine compounds
07/08/2010CA2748274A1 Heteroaryl compounds useful as raf kinase inhibitors
07/08/2010CA2748233A1 A composition comprising nor-adrenaline and a net inhibitor for administering to a brain-dead, heart-beating potential organ donor
07/08/2010CA2748174A1 Substituted 1h-pyrazolo[3,4-d]pyrimidine-6-amine compounds
07/08/2010CA2748160A1 Novel use of fibrates
07/08/2010CA2748066A1 Method of preparing (+)-1,4-dihydro-7-[(3s,4s)-3methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
07/08/2010CA2747667A1 Acne treatment powder foundation
07/08/2010CA2747641A1 Substituted (thiophenyl-carbonyl)imidazolidinones, and use thereof
07/08/2010CA2747640A1 Substituted furancarboxamides, and use thereof
07/08/2010CA2747602A1 3.1.0 bicyclic glyt1 inhibitors and methods of making and using same
07/08/2010CA2747582A1 Methods for increasing endogenous plasmalogen levels
07/08/2010CA2747310A1 Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof
07/08/2010CA2747158A1 Phthalazinone and related analogs as sirtuin modulators
07/08/2010CA2747126A1 Frequency modulated drug delivery (fmdd)
07/08/2010CA2747094A1 Substituted 4-(1,2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as kcnq2/3 modulators
07/08/2010CA2746871A1 Monohydrate of 4-({(4-carboxybutyl)[2-(2-{[4-(2-phenylethyl)benzyl]oxy}phenyl)ethyl]-amino}methyl)benzoic acid
07/08/2010CA2746870A1 Modification i of 4-({4-carboxybutyl)[2-(2-{[4-(2-phenylethyl)benzyl]oxy}phenyl)ethyl]-amino}methyl)benzoic acid
07/08/2010CA2746811A1 Antioxidant-containing food composition for use in inhibiting histamine pathways in companion animals
07/08/2010CA2746790A1 Toluidine sulfonamides and their use
07/08/2010CA2746769A1 Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals
07/08/2010CA2746768A1 Enema formulations
07/08/2010CA2746767A1 Oral formulations
07/08/2010CA2746612A1 Phenylalkyl-imidazole-bisphosphonate compounds
07/08/2010CA2746566A1 Topical herbal formulation for treatment of acne and skin disorders
07/08/2010CA2746506A1 Method of modulating hsf-1
07/08/2010CA2746423A1 Aminopyrazole compounds as chki inhibitors
07/08/2010CA2746307A1 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
07/08/2010CA2746295A1 N-(1-phenyl-2-arylethyl)-4,5-dihydro-3h-pyrrol-2-amine compounds as subtype selective modulators of alpha2b or alpha2b and alpha2c adrenoceptors
07/08/2010CA2746221A1 Isoindolinone and related analogs as sirtuin modulators
07/08/2010CA2745930A1 Topically active steroids for use in radiation and chemotherapeutics injury
07/08/2010CA2745503A1 Novel oxime derivatives of 3,5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same
07/08/2010CA2745445A1 Inhibitors of diacylglycerol aclytransferase
07/08/2010CA2745295A1 Modulators of toll-like receptors
07/08/2010CA2745071A1 C-ring modified tricyclic benzonaphthiridinone protein kinase inhibitors and use thereof
07/08/2010CA2744221A1 Antagonists of lysophosphatidic acid receptors
07/08/2010CA2744056A1 Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals
07/07/2010EP2204398A1 Camptothecin polymer derivative and uses of the same
07/07/2010EP2204387A1 Novel chondroitin sulfate having decreased molecular weight and use thereof
07/07/2010EP2204374A1 Nucleoside phosphonates and analogs thereof for the treatment of HPV-infections
07/07/2010EP2204368A1 4-sulfonylpiperidine derivatives
07/07/2010EP2204367A1 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
07/07/2010EP2204365A1 Alkylsulfone derivative
07/07/2010EP2204364A1 Polymorphs of donepezil salts, preparation methods and uses thereof
07/07/2010EP2204363A1 New disubstituted phenylpiperidines/piperazines as modulators of dopamine neurotransmission
07/07/2010EP2204361A1 13-substituted methacycline compounds
07/07/2010EP2204360A1 Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient
07/07/2010EP2204192A1 Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient
07/07/2010EP2204182A1 Non-cytotoxic protein conjugates
07/07/2010EP2204177A1 Cancer marker and therapeutic agent for cancer
07/07/2010EP2204176A2 Nutritional Composition
07/07/2010EP2204175A1 Therapeutic agent for inflammatory bowel disease comprising uracil derivative as active ingredient
07/07/2010EP2204174A1 Metronidazole solubilisation process with niacinamide and two glycols, and the resulting solution
07/07/2010EP2204173A1 Antidiabetic pharmaceutical composition
07/07/2010EP2204172A1 Agent having neurotrophic factor-like activity
1 ... 2185 2186 2187 2188 2189 2190 2191 2192 2193 2194 2195 2196 2197 2198 2199 2200 2201 2202 2203 2204 2205 ... 7860